Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2013

Sep 13, 2013

30786_dirs_2013-09-13_799ed83a-8d19-4622-b718-7f0692922d57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2013-09-11

Reporting Person: Magni Giovanni (EVP, Intl Sales)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-12 Bio-Rad A Common Stock M 240 Acquired 8708 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-11 Restricted Stock Units $0 A 1200 Acquired Bio-Rad A Common Stock (1200) Direct
2013-09-11 Non-Qualified Stock Option (right to buy) $117.00 A 3200 Acquired 2023-09-11 Bio-Rad A Common Stock (3200) Direct
2013-09-12 Restricted Stock Units $0 M 240 Disposed Bio-Rad A Common Stock (240) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F5: The restricted stock units vest in five equal annual installments beginning September 12, 2013.